Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
- Drug Distributor Exits Opioid Market After Admitting Role in Crisis. Reuters. January 14, 2020.
A New York company that was the first drug distributor to face U.S. felony charges for its role in fueling the opioid crisis said it will stop distributing controlled pharmaceuticals, including opioids.
2) What Big Tech Companies Aren’t Saying About HHS Data Rules. Politico. January 10, 2020.
Hospitals and doctors are pitted against patient data advocates in a debate over HHS plans to facilitate data sharing with software companies. But the biggest tech players — Google, Facebook, Amazon and others — have largely remained quiet.
3) Eli Lilly to Acquire Dermira for $1.1 Billion. Stat News. January 10, 2020.
Eli Lilly said that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.
4) Trump Administration Tells Supreme Court No Need to Rush an Obamacare Ruling. The Washington Post. January 10, 2020.
The Trump administration said the court should not grant a motion by the House of Representatives and Democratic-led states to expedite review of a decision by a panel of the U.S. Court of Appeals. The panel struck down the law’s mandate that individuals buy health insurance but sent back to a lower court the question of whether the rest of the statute can stand without it.
5) FDA Makes Real-World Data Available on Google Cloud Platform. Health IT Analytics. January 10, 2020.
The FDA’s MyStudies platform, a tool that aims to collect real-world data to improve clinical trials and advance medical research, is now available on Google Cloud Platform.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. Click here to Subscribe.
